Novo Nordisk A/S (ADR) (NYSE:NVO)

CAPS Rating: 5 out of 5

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.


Player Avatar blesto (31.02) Submitted: 7/21/2011 6:31:45 AM : Outperform Start Price: $23.99 NVO Score: +8.00

Alzhiemer's trials with a diabetes drug?

Report this Post 2 Replies
Member Avatar ROEoutshinesGOLD (99.34) Submitted: 8/4/2011 1:08:58 AM
Recs: 0

That's cool, good company, GO Jags

Member Avatar blesto (31.02) Submitted: 8/4/2011 7:00:14 PM
Recs: 0

Thanx man! For more Foolish Football talk, go to;

Featured Broker Partners